Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$306.88 - $380.0 $3,375 - $4,180
11 Added 7.33%
161 $61,000
Q3 2023

Nov 13, 2023

BUY
$315.92 - $397.36 $4,738 - $5,960
15 Added 11.11%
150 $48,000
Q2 2023

Aug 15, 2023

BUY
$346.15 - $392.09 $29,076 - $32,935
84 Added 164.71%
135 $52,000
Q1 2023

Apr 27, 2023

BUY
$323.56 - $373.36 $6,794 - $7,840
21 Added 70.0%
51 $19,000
Q4 2022

Feb 07, 2023

SELL
$248.67 - $334.17 $15,914 - $21,386
-64 Reduced 68.09%
30 $10,000
Q3 2022

Oct 28, 2022

BUY
$263.81 - $337.27 $4,484 - $5,733
17 Added 22.08%
94 $25,000
Q1 2022

May 04, 2022

BUY
$379.46 - $424.54 $1,517 - $1,698
4 Added 5.48%
77 $32,000
Q4 2021

Feb 07, 2022

BUY
$373.53 - $434.12 $1,494 - $1,736
4 Added 5.8%
73 $31,000
Q2 2021

Aug 11, 2021

BUY
$372.36 - $412.07 $25,692 - $28,432
69 New
69 $27,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.